185 related articles for article (PubMed ID: 33284998)
1. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases.
Zhu HB; Xu D; Ye M; Sun L; Zhang XY; Li XT; Nie P; Xing BC; Sun YS
Int J Cancer; 2021 Apr; 148(7):1717-1730. PubMed ID: 33284998
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
[TBL] [Abstract][Full Text] [Related]
3. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
4. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
[TBL] [Abstract][Full Text] [Related]
5. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
7. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
[TBL] [Abstract][Full Text] [Related]
8. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
9. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
Liu LH; Zhou GF; Lv H; Wang ZC; Rao SX; Zeng MS
Eur Radiol; 2021 Aug; 31(8):5640-5649. PubMed ID: 33449175
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy.
Zhu HB; Xu D; Zhang XY; Li XT; Xing BC; Sun YS
Ann Surg Oncol; 2022 Jun; 29(6):3938-3949. PubMed ID: 35013857
[TBL] [Abstract][Full Text] [Related]
11. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
12. The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.
Karagkounis G; Cai G; Johnson PT; Pawlik TM; Fishman EK; Choti MA
Ann Surg Oncol; 2015 Jul; 22(7):2201-8. PubMed ID: 25582736
[TBL] [Abstract][Full Text] [Related]
13. Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.
Creasy JM; Midya A; Chakraborty J; Adams LB; Gomes C; Gonen M; Seastedt KP; Sutton EJ; Cercek A; Kemeny NE; Shia J; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI; Do RKG; Simpson AL
Eur Radiol; 2019 Jan; 29(1):458-467. PubMed ID: 29922934
[TBL] [Abstract][Full Text] [Related]
14. Prediction of hepatic lymph node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection.
Zhu HB; Xu D; Sun XF; Li XT; Zhang XY; Wang K; Xing BC; Sun YS
Cancer Imaging; 2023 Feb; 23(1):18. PubMed ID: 36810192
[TBL] [Abstract][Full Text] [Related]
15. Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases.
Matsuki R; Mise Y; Saiura A; Inoue Y; Ishizawa T; Takahashi Y
Surgery; 2016 Nov; 160(5):1256-1263. PubMed ID: 27521044
[TBL] [Abstract][Full Text] [Related]
16. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
17. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.
Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE
HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631
[TBL] [Abstract][Full Text] [Related]
19. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response.
Boraschi P; Donati F; Cervelli R; Pacciardi F; Tarantini G; Castagna M; Urbani L; Lencioni R
Eur J Radiol; 2021 Apr; 137():109609. PubMed ID: 33647779
[TBL] [Abstract][Full Text] [Related]
20. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
